Crossmark

Mechanical Thrombectomy—A Brief Review of a Revolutionary new Treatment for Thromboembolic Stroke

Crossref DOI link: https://doi.org/10.1007/s00062-018-0692-2

Published Online: 2018-05-09

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhogal, Pervinder

Andersson, Tommy

Maus, Volker

Mpotsaris, Anastasios

Yeo, Leonard https://orcid.org/0000-0002-4249-0402
License Information

Text and Data Mining valid from 2018-05-09
More Information

Article History

Received: 26 March 2018

Accepted: 17 April 2018

First Online: 9 May 2018

Conflict of interest

: T. Andersson is a consultant for Ablynx, Amnis Therapeutics, Medtronic, Cerenovus-Neuravi, Rapid Medical and Stryker. P. Bhogal is consultant for Neurvana Medical and Phenox. L. Yeo has received substantial grant funding from the National Medical Research Council (NMRC), Singapore, substantial grant funding from the Ministry of Health (MOH), Singapore and a moderate grant funding from IR, A‑STAR, Singapore. V. Maus and A. Mpotsaris declare that they have no competing interests.